Randomized Blinded Phase II Trial of Maintenance SU011248 Versus Placebo Post Chemotherapy Patients With Advanced Urothelial Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 08 Jun 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 08 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2010 New trial record